CAR-T Therapy for Primary central nervous system Lymphoma at Sheba Medical Center
What's included in this package
Medical Procedures
- CAR T-cell therapy
- Blood tests
- Biochemistry blood test
- Biopsy
- CT Scan
- Consultation with a doctor
- Consultation with an oncologist
- Consultation with a hematologist
- Consultation with a surgeon
- Consultation with a neurologist
- Consultation of a radiologist
- Complete blood count with cancer markers and a proteinogram
- CT angiography
- Electrocardiogram (ECG)
- Head MRI
- Post-operative care
- Preoperative tests
- PET/CT
- Сonsultation with an oncohematologist
- 24-hr nurse services
- 3 meals per day by nutritionist
Duration
- 21 days in the hospital
Accommodation
Hospitalization
Transport
Transfer airport-clinic-airport
Additional information
CAR-T Therapy for Primary CNS Lymphoma at Sheba Medical Center
For patients diagnosed with Primary central nervous system Lymphoma (PCNSL), a rare and complex cancer affecting the brain and central nervous system, choosing the right treatment center is critical.
Sheba Medical Center, one of the world’s leading hospitals, offers advanced CAR-T cell therapy, providing new hope for patients with relapsed or treatment-resistant disease.
Sheba combines cutting-edge immunotherapy with deep expertise in neuro-oncology, delivering highly personalized care for even the most challenging cases.
A Faster Path to Advanced Treatment
At Sheba, the entire CAR-T process is performed on-site, ensuring speed, precision, and optimal cell quality crucial for patients with aggressive CNS disease.
• Apheresis – collection of the patient’s T-cells
• Cell Engineering – genetic modification at Sheba’s Advanced Biotherapy Center
• Infusion – reintroduction of modified cells designed to target lymphoma cells, including those within the central nervous system
By avoiding external laboratories, treatment can begin in approximately 10 days, significantly reducing delays and allowing faster access to life-saving therapy.
CAR-T acts as a “living therapy,” continuing to work inside the body and offering the potential for long-term disease control and remission.
All patients are treated under the leadership of Prof. Arnon Nagler, a globally recognized expert in hemato-oncology.
Proven Expertise in Complex Cases
Primary CNS lymphoma requires a highly specialized, multidisciplinary approach. At Sheba, hematologists, neuro-oncologists, neurologists, and imaging specialists work together to design the most effective treatment strategy for each patient.
CAR-T therapy offers a promising option for patients who have exhausted conventional treatments, with encouraging remission outcomes even in advanced cases.
Why Patients Choose Sheba
• Rapid access to CAR-T therapy – treatment initiation in ~10 days
• Extensive experience – leading CAR-T program in the region
• Dedicated CAR-T units – with 24/7 expert monitoring
• Multidisciplinary CNS expertise – integrated hematology and neuro-oncology care
• Full international support – medical review, travel coordination, and patient assistance
Comprehensive, Personalized Care
Each patient undergoes a full evaluation, including advanced brain imaging (MRI/CT), molecular and genetic testing, and complete medical assessment, ensuring a precise and individualized treatment plan.
Services are available in English, Russian, and Arabic, providing a smooth and supportive experience for international patients.
A Leading Center for Advanced Neuro-Oncology Care
By combining innovative CAR-T technology, in-house cell production, and multidisciplinary expertise, Sheba offers one of the most advanced treatment options for Primary CNS Lymphoma worldwide giving patients access to therapies that can extend survival and improve quality of life.
24/7 Bookimed assistance
- Personal medical coordinator
- Medical travel arrangements — booking of air tickets and hotel rooms at special partner prices
- Patient advocacy during medical travel
Program price
What's NOT included in this package
Doctor
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
How are we doing?
About the clinic
Sheba Medical Center, Israel’s leading hospital, is consistently ranked among the world’s top institutions. Treating over 2 million patients annually, Sheba combines world-class expertise with compassionate, personalized care. Its “City of Health” campus integrates six specialized hospitals, offering advanced treatments in oncology, neurology, cardiology, orthopedics, and more. Sheba is a global leader in CAR-T and TIL immunotherapies, precision medicine, and minimally invasive surgery, making it a trusted destination for international patients seeking cutting-edge healthcare.
Payment & Rewards
You don’t pay for our services
You make your payment directly at the clinic or to their official bank account.
Some clinics may require a deposit as a part of their policy.
Spread out your payments with installment options.
Earn rewards for referring friends to Bookimed.